Dr. Reddy's Laboratories Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Mar 24, 2025 · CIK: 1135951
| Field | Detail |
|---|---|
| Company | Dr Reddys Laboratories Ltd (RDY) |
| Form Type | 6-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-issuer
TL;DR
DRL filed a 6-K on 3/24, standard reporting for a foreign issuer. Nothing major.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on March 24, 2025, reporting information as of March 22, 2025. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer. This filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates and disclosures for Dr. Reddy's Laboratories, ensuring transparency for investors and regulatory bodies regarding its ongoing operations and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain information that suggests a significant change in the company's risk profile.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-25-000253 (accession_number) — Filing identifier
- 20250324 (date) — Filing date
- 20250322 (date) — Period of report
- 0001135951 (central_index_key) — Company identifier
- 2834 (sic_code) — Standard Industrial Classification
- 001-15182 (sec_file_number) — SEC file number
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information to the SEC.
When was this Form 6-K filed?
The filing date for this Form 6-K is March 24, 2025.
What period does this report cover?
The conformed period of report for this filing is March 22, 2025.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address of Dr. Reddy's Laboratories?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 24, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).